Genetic susceptibility for breast cancer: risk assessment and counselingANG, Peter; GARBER, Judy E.Seminars in oncology. 2001, Vol 28, Num 4, pp 419-433, issn 0093-7754Article

Long-term outcomes of children exposed to antineoplastic agents in uteroPARTRIDGE, Ann H; GARBER, Judy E.Seminars in oncology. 2000, Vol 27, Num 6, pp 712-726, issn 0093-7754Article

Complementary and alternative medicine use among women with breast cancerDIGIANNI, Lisa M; GARBER, Judy E; WINER, Eric P et al.Journal of clinical oncology. 2002, Vol 20, Num 18, pp 34s-38s, issn 0732-183X, SUPArticle

Hereditary cancer predisposition syndromesGARBER, Judy E; OFFIT, Kenneth.Journal of clinical oncology. 2005, Vol 23, Num 2, pp 276-292, issn 0732-183X, 17 p.Article

Complementary medicine use before and 1 year following genetic testing for BRCA1/2 mutationsDIGIANNI, Lisa M; RUE, Montserrat; EMMONS, Karen et al.Cancer epidemiology, biomarkers & prevention. 2006, Vol 15, Num 1, pp 70-75, issn 1055-9965, 6 p.Article

Disclosure of familial genetic information : Perceptions of the duty to informLEHMANN, Lisa Soleymani; WEEKS, Jane C; KLAR, Neil et al.The American journal of medicine. 2000, Vol 109, Num 9, pp 705-711, issn 0002-9343Article

Physicians' Experiences With BRCA1/2 Testing in Community SettingsKEATING, Nancy L; STOECKERT, Kathryn A; REGAN, Meredith M et al.Journal of clinical oncology. 2008, Vol 26, Num 35, pp 5789-5796, issn 0732-183X, 8 p.Article

Comprehensive Molecular Analysis of Mismatch Repair Gene Defects in Suspected Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer) CasesMUELLER, James; GAZZOLI, Isabella; BANDIPALLIAM, Prathap et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 17, pp 7053-7061, issn 0008-5472, 9 p.Article

Evaluation of established breast cancer risk factors as modifiers of BRCA1 or BRCA2: a multi-center case-only analysisMOORMAN, Patricia G; IVERSEN, Edwin S; SUSSWEIN, Lisa et al.Breast cancer research and treatment. 2010, Vol 124, Num 2, pp 441-451, issn 0167-6806, 11 p.Article

Local therapy in BRCA1 and BRCA2 mutation carriers with operable breast cancer: comparison of breast conservation and mastectomyPIERCE, Lori J; PHILLIPS, Kelly-Anne; MERAJVER, Sofia D et al.Breast cancer research and treatment. 2010, Vol 121, Num 2, pp 389-398, issn 0167-6806, 10 p.Article

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trialTUTT, Andrew; ROBSON, Mark; WARDLEY, Andrew et al.Lancet (British edition). 2010, Vol 376, Num 9737, pp 235-244, issn 0140-6736, 10 p.Article

AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers : A consortium of investigators of modifiers of BRCA1/2 studyCOUCH, Fergus J; SINILNIKOVA, Olga; PEOCK, Susan et al.Cancer epidemiology, biomarkers & prevention. 2007, Vol 16, Num 7, pp 1416-1421, issn 1055-9965, 6 p.Article

Effect of factor V leiden and prothrombin G20210h→A mutations on thromboembolic risk in the national surgical adjuvant breast and bowel project breast cancer prevention trialABRAMSON, Neil; COSTANTINO, Joseph P; GARBER, Judy E et al.Journal of the National Cancer Institute. 2006, Vol 98, Num 13, pp 904-910, issn 0027-8874, 7 p.Article

Familial gastrointestinal stromal tumor syndrome : Phenotypic and molecular features in a kindredLI, Frederick P; FLETCHER, Jonathan A; HEINRICH, Michael C et al.Journal of clinical oncology. 2005, Vol 23, Num 12, pp 2735-2743, issn 0732-183X, 9 p.Article

Sex ratio distortion in offspring of families with BRCA1 or BRCA2 mutant alleles : an ascertainment bias phenomenon?BALMANA, Judith; DIEZ, Orland; CAMPOS, Berta et al.Breast cancer research and treatment. 2005, Vol 92, Num 3, pp 273-277, issn 0167-6806, 5 p.Article

Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPROEUHUS, David M; SMITH, Kristin C; ESSERMAN, Laura et al.Journal of the National Cancer Institute. 2002, Vol 94, Num 11, pp 844-851, issn 0027-8874, 8 p.Article

Prevalence of germline TP53 mutations in HER2+ breast cancer patientsRATH, Michelle G; MASCIARI, Serena; GARBER, Judy E et al.Breast cancer research and treatment. 2013, Vol 139, Num 1, pp 193-198, issn 0167-6806, 6 p.Article

Clinical Outcome of Triple Negative Breast Cancer in BRCA1 Mutation Carriers and NoncarriersLEE, Larissa J; ALEXANDER, Brian; SCHNITT, Stuart J et al.Cancer. 2011, Vol 117, Num 14, pp 3093-3100, issn 0008-543X, 8 p.Article

Occult ovarian cancers identified at risk-reducing salpingo-oophorectomy in a prospective cohort of BRCA1/2 mutation carriersDOMCHEK, Susan M; FRIEBEL, Tara M; LYNCH, Henry T et al.Breast cancer research and treatment. 2010, Vol 124, Num 1, pp 195-203, issn 0167-6806, 9 p.Article

Basal Cytokeratin and Epidermal Growth Factor Receptor Expression Are Not Predictive of BRCA1 Mutation Status in Women With Triple-negative Breast CancersCOLLINS, Laura C; MARTYNIAK, Anthony; KANDEL, Michaela J et al.The American journal of surgical pathology. 2009, Vol 33, Num 7, pp 1093-1097, issn 0147-5185, 5 p.Article

Risk-Reducing Salpingo-Oophorectomy for the Prevention of BRCA1-and BRCA2-Associated Breast and Gynecologic Cancer : A Multicenter, Prospective StudyKAUFF, Noah D; DOMCHEK, Susan M; NEUHAUSEN, Susan L et al.Journal of clinical oncology. 2008, Vol 26, Num 8, pp 1331-1337, issn 0732-183X, 7 p.Article

VEGF as a Marker for Outcome Among Advanced Breast Cancer Patients Receiving anti-VEGF Therapy with Bevacizumab and Vinorelbine ChemotherapyBURSTEIN, Harold J; CHEN, Yu-Hui; SHULMAN, Lawrence N et al.Clinical cancer research (Print). 2008, Vol 14, Num 23, pp 7871-7877, issn 1078-0432, 7 p.Article

Research Issues Affecting Preoperative Systemic Therapy for Operable Breast CancerWOLFF, Antonio C; BERRY, Donald; SMITH, Mary Lou et al.Journal of clinical oncology. 2008, Vol 26, Num 5, pp 806-813, issn 0732-183X, 8 p.Article

The role of prevention in oncology practice : Results from a 2004 survey of american society of clinical oncology membersGANZ, Patricia A; KWAN, Lorna; SOMERFIELD, Mark R et al.Journal of clinical oncology. 2006, Vol 24, Num 18, pp 2948-2957, issn 0732-183X, 10 p.Article

Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers : The PROSE study groupREBBECK, Timothy R; FRIEBEL, Tara; EELES, Rosalind et al.Journal of clinical oncology. 2005, Vol 23, Num 31, pp 7804-7810, issn 0732-183X, 7 p.Article